Oral Cancer Screening Facts

Every hour, one American dies from oral cancer.

When diagnosed early, a person with oral cancer has an 80 - 90% survival rate.

All new Metro Dentalcare patients receive information about oral cancer and oral cancer screenings at their first appointment.

Oral Cancer Screening

Metro Dentalcare's dentists and dental professionals are trained in oral cancer screening methods. They are dedicated to educating patients about the disease and providing thorough screenings to detect oral cancer before it's too late.

New patients at Metro Dentalcare will notice their dentists give them introductory information on oral cancer and oral cancer screenings. Schedule your oral cancer screening today.

Learn more about oral cancer

ViziLite® Plus

In addition to oral cancer training, dentists at Metro Dentalcare use a special supplemental technology to help in oral cancer screenings called ViziLite Plus. This advanced light technology helps detect oral abnormalities, ensuring our patients receive the most comprehensive oral cancer screening possible.

ViziLite Plus is a simple, painless and non-invasive technology that improves the doctor's ability to visualize, mark, evaluate and monitor suspicious areas at their earliest stages, before they can progress to something far more serious, and potentially life-threatening. ViziLite Plus helps the doctor see what can't be seen with the unaided eye. Metro Dentalcare recommends your dentist perform an oral cancer screening during every annual check-up. Learn more about ViziLite Plus.
 

    

 

Regular Dental Exams Are Important

It is now easier than ever to detect oral cancer early, when the opportunity for a cure is great. Currently only half of all patients diagnosed with oral cancer survive more than five years. Regular dental check-ups, including an examination of the entire mouth, are essential in the early detection of cancerous and pre-cancerous conditions. You may have a very small, but dangerous, oral spot or sore and not be aware of it (source: ADA).